U.S. P2Y12 Inhibitors Market is Estimated to Witness High Growth...

added article Other

U.S. P2Y12 Inhibitors Market is Estimated to Witness High Growth Owing to Advancements in Targeted Therapy

The U.S. P2Y12 inhibitors market comprises products such as cangrelor, ticagrelor, and clopidogrel; which are primarily used for preventing platelet aggregation and reduce the risk of heart attacks or ischemia in patients suffering from cardiac conditions. P2Y12 inhibitors work by inhibiting the P2Y12 receptor and blocking the ADP-induced activation and aggregation of platelets. The advantages...

0 Comments 0 Shares